
Immunising infants and older people against RSV found to not be cost-effective - HIQA
4/28/2026
0:00
2:54
Dr. Máirín Ryan, HIQA Director of Health Technology Assessment, explains its assessment of immunisation programmes against RSV.
See omnystudio.com/listener for privacy information.
More episodes from "Morning Ireland"



Don't miss an episode of “Morning Ireland” and subscribe to it in the GetPodcast app.








